Gilead begins testing inhalable form of remdesivir for COVID-19
The company said the trial will test the drug particularly in those cases where the disease has not progressed to require…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
COVID-19 Updates
EU secures potential COVID-19 drugs from Roche, Germany’s Merck – source
The deals cover Roche’s arthritis drug RoActemra and Merck’s multiple sclerosis drug Rebif - both seen as potential COVID-19…
Potential COVID-19 vaccine not ‘single solution’ to pandemic, Johnson & Johnson CEO…
Gorsky said it was a good thing other companies are experimenting with different approaches to vaccines, in part because different…
Cipla launches Cipremi, likely to price it Rs 4,000 per vial
It is looking to supply over 80,000 vials within the first month
Premas Biotech initiates triple antigen VLP COVID-19 vaccine candidate for animal trials
At the moment, it is the only one from India to adopt a triple-antigen approach that is designed to produce an enhanced immune…
Pharma firms initiate steps to curb black marketing of remedisivir
Measures include constant monitoring of the drug’s usage and ensuring its uninterrupted supply by working in collaboration with…
Blueprint for self-reliance in the bio-pharma sector
Gaurav Kaushik, MD & CEO, Meteoric Biopharmaceuticals highlights that the COVID-19 crisis has opened a window of opportunity…
Doctors view ‘antiviral agents’ as the most effective therapeutic option for treating COVID-19:…
Anti-inflammatory drugs, convalescent plasma therapy are opined to be the next-best treatments; AI, ML, Big Data and IoT emerge as…
China’s Sinovac starts late stage trials for its COVID-19 vaccine
Moderna also plans to start its late-stage trial this month
Serum Institute of India expects COVID vaccine by year-end
He was speaking during the launch of 'Compact XL, a compact diagnostics machine by MyLab Discovery Solutions, that will automate…